4
Changes in Ownership
Dianthus Therapeutics, Inc. /DE/ Filed Acc 0001779934-26-000004
Director sold 7,750 shares at an average $109.01 ($844,822)
- Director acquired 7,750 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| McGeorge Anne Director | 2026-08-10 | Option exercise 10b5-1 | +1,250 | $19.36 | $24,200 | 1,250 | D |
| McGeorge Anne Director | 2026-08-10 | Option exercise 10b5-1 | +6,500 | $11.20 | $72,800 | 7,750 | D |
| McGeorge Anne Director | 2026-08-10 | Sale 10b5-1 | −1,450 | $107.58 | $155,991 | 6,300 | D |
| McGeorge Anne Director | 2026-08-10 | Sale 10b5-1 | −2,800 | $108.38 | $303,464 | 3,500 | D |
| McGeorge Anne Director | 2026-08-10 | Sale 10b5-1 | −1,800 | $109.30 | $196,740 | 1,700 | D |
| McGeorge Anne Director | 2026-08-10 | Sale 10b5-1 | −1,000 | $110.64 | $110,640 | 700 | D |
| McGeorge Anne Director | 2026-08-10 | Sale 10b5-1 | −700 | $111.41 | $77,987 | 0 | D |
| Derivatives | |||||||
| McGeorge Anne Director | 2026-08-10 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,250 | 0 | D | ||
| McGeorge Anne Director | 2026-08-10 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −6,500 | 0 | D | ||
| Open-market sales · 7,750 sh · avg $109.01 · $844,822 | |||||||
Loading xslF345X06/ownership.xml…